Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/β-catenin signaling in human colon cancer cells

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 332-342

  Yamada, Nami ^a   Noguchi, Shunsuke ^a   Mori, Takashi ^a   Naoe, Tomoki ^b   Maruo, Kohji ^a   Akao, Yukihiro ^a  

^a GIFU UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Catenin 1; Colon cancer; MiR 145; Wnt catenin signaling

Indexed keywords

BETA CATENIN; CATENIN; CYCLIN D1; DELTA CATENIN 1; GLYCOSYLTRANSFERASE INHIBITOR; MICRORNA 145; P21 ACTIVATED KINASE 4; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; XAV 939;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLON CANCER; COLON CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLIND1 GENE; DOWN REGULATION; DRUG POTENTIATION; GENE EXPRESSION; GENE FUNCTION; GENETIC REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOCYTOPLASMIC TRANSPORT; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN TARGETING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ACTIVE TRANSPORT, CELL NUCLEUS; BETA CATENIN; CATENINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; DOWN-REGULATION; GENES, MYC; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; MICRORNAS; P21-ACTIVATED KINASES; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA, SMALL INTERFERING; TANKYRASES; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84878221927     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.060     Document Type: Article

References (41)

1. Cho W.C. MicroRNAs in cancer - from research to therapy. Biochem. Biophys. Acta 1805, 2010:209-217.
2. Kloosterman W.P., Plasterk R.H.A. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
3. Schetter A.J., Harris C.C. Alterations of microRNAs contribute to colon carcinogenesis. Semin. Oncol. 2011, 38:734-742.
4. Akao Y., Nakagawa Y., Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007, 26:311-320.
5. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010, 17:398-408.
6. Iio A., Nakagawa Y., Hirata I., Naoe T., Akao Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol. Cancer 2010, 9:136.
7. Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep. 2006, 16:845-850.
8. 1 regulators. Mol. Cancer Res. 2011, 9:960-975.
9. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y.Y. P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 2009, 106:3207-3212.
10. Cho W.C., Chow A.S., Au J.S. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011, 8:125-131.
11. Gregersen L.H., Jacobsen A.B., Frankel L.B., Wen J., Krogh A., Lund A.H. MicroRNA-145 targets Yes and STAT1 in colon cancer cells. PLoS One 2010, 5:e8836.
12. Chiyomaru T., Enokida H., Tatarano S., Kawahara K., Uchida Y., Nishiyama K., Fujimura L., Kikkawa N., Seki N., Nakagawa M. MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 2010, 102:883-891.
13. Xu Q., Liu L.Z., Qian X., Chen Q., Jiang Y., Li D., Lai L., Jiang B.H. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012, 40:761-774.
14. Rowan A.J., Lamlum H., Ilyas M., Wheeler J., Straub J., Papadopoulou A., Bicknell D., Bodmer W.F., Tomlinson I.P. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc. Natl. Acad. Sci. USA 2000, 97:3352-3357.
15. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2006, 127:469-480.
16. Fearon E.R., Vogelstein B.A. Genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
17. Polakis P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 1999, 9:15-21.
18. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., Knuechel R., Kirchner T. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 2001, 98:10356-10361.
19. Phelps R.A., Chidester S., Dehghanizadeh S., Phelps J., Sandoval I.T., Rai K., Broadbent T., Sarkar S., Burt R.W., Jones D.A. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 2009, 137:623-634.
20. Wong L.E., Reynolds A.B., Dissanayaka N.T., Minden A. P120-catenin is a binding partner and substrate for group B Pak kinases. J. Cell Biochem. 2010, 110:1244-1254.
21. Li Y., Shao Y., Tong Y., Shen T., Zhang J., Li Y., Gu H., Li F. Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling. Biochim. Biophys. Acta 1823, 2012:465-475.
22. Noguchi P., Wallace R., Johnson J., Earley E.M., O'Brien S., Ferrone S., Pellegrino M.A., Milstien J., Needy C., Browne W., Petricciani J. Characterization of the WIDR: a human colon carcinoma cell line. In Vitro 1979, 15:401-408.
23. Noguchi S., Mori T., Hoshino Y., Maruo K., Yamada N., Kitade Y., Naoe T., Akao Y. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 2011, 307:211-220.
24. Anastasiadis P.Z. P120-ctn: a nexus for contextual signaling via Rho GTPases. Biochim. Biophys. Acta 2007, 1773:34-46.
25. Anastasiadis P.Z., Reynolds A.B. Regulation of Rho GTPases by p120-catenin. Curr. Opin. Cell Biol. 2001, 13:604-610.
26. Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A., Charlat O., Wiellette E., Zhang Y., Wiessner S., Hild M., Shi X., Wilson C.J., Mickanin C., Myer V., Fazal A., Tomlinson R., Serluca F., Shao W., Cheng H., Shultz M., Rau C., Schirle M., Schlegl J., Ghidelli S., Fawell S., Lu C., Curtis D., Kirschner M.W., Lengauer C., Finan P.M., Tallarico J.A., Bouwmeester T., Porter J.A., Bauer A., Cong F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signaling. Nature 2009, 461:614-620.
27. Ostenfeld M.S., Bramsen J.B., Lamy P., Villadsen S.B., Fristrup N., Sørensen K.D., Ulhøi B., Borre M., Kjems J., Dyrskjøt L., Orntoft T.F. MiR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 2010, 29:1073-1084.
28. Sudbery I., Enright A.J., Fraser A.G., Dunham I. Systemic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis. BMC Genomics 2010, 11:175.
29. Noguchi S., Yamada N., kumazaki M., Yasui Y., Iwasaki J., Naito S., Akao Y. Socs7, a target gene of microRNA-145 regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells. Cell Death Dis. 2013, 10.1038/cddis.2013.11.
30. Schepeler T., Holm A., Halvey P., Nordentoft I., Lamy P., Riising E.M., Christensen L.L., Thorsen K., Liebler D.C., Helin K., Ørntoft T.F., Andersen C.L. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene 2012, 31:2750-2760.
31. Reynolds A.B., Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 2004, 23:7947-7956.
32. ctn and the transcription factor Kaiso. Biochim. Biophys. Acta 2007, 1773:59-68.
33. Daniel J.M., Reynolds A.B. The catenin p120 (ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell Biol. 1999, 19:3614-3623.
34. Wang Z., Zhang X., Yang Z., Du H., Wu Z., Gong J., Yan J., Zheng Q. MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochem. Biophys. Res. Commun. 2012, 427:444-449.
35. Kim H., He Y., Yang I., Zeng Y., Kim Y., Seo Y.M., Murnane M.J., Jung C., Lee J.H., Min J.J., Kwon D.D., Kim K.K., Lu Q., Kim K. δ-Catenin promotes E-cadherin processing and activates β-catenin-mediated signaling: implications on human prostate cancer progression. Biochim. Biophys. Acta 1822, 2012:509-521.
36. Davis M.A., Ireton R.C., Reynolds A.B. A core function for p120-catenin in cadherin turnover. J. Cell Biol. 2003, 163:525-534.
37. Ireton R.C., Davis M.A., van Hengel J., Mariner D.J., Barnes K., Thoreson M.A., Anastasiadis P.Z., Matrisian L., Bundy L.M., Sealy L., Gilbert B., van Roy F., Reynolds A.B. A novel role for p120 catenin in E-cadherin function. J. Cell Biol. 2002, 159:465-476.
38. Wells C.M., Whale A.D., Parsons M., Masters J.R., Jones G.E. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J. Cell Sci. 2010, 123:1663-1673.
39. Zhang H., Li Z., Viklund E.K., Stromblad S. P21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J. Cell Biol. 2002, 158:1287-1297.
40. Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., Chiyomaru T., Enokida H., Nakagawa M., Matsubara H. MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:2804-2814.
41. Fuse M., Nohata N., Kojima S., Sakamoto S., Chiyomaru T., Kawakami K., Enokida H., Nakagawa M., Naya Y., Ichikakwa T., Seki N. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int. J. Oncol. 2011, 38:1093-1101.